[131I]I-GMIB-4AH29

N/A

Report date: 2025/10/30 15:24:43

Base Information

Drug Name[131I]I-GMIB-4AH29

Drug Alias Name[131I]I-guanidinomethyl iodobenzoate (GMIB)-4AH29[131I]I-GMIB-4AH29

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)Radiation-emitting products > Nuclides > Iodine > 131IRadiation-emitting products > Radioactive diagnostic agent +[6]

Mechanisms of ActionFibroblast activation protein alpha modulatorsPositron-emission tomography enhancers

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPrecirix NV/SA

China Registration ClassN/A

Develop Information

Active CompaniesPrecirix NV/SA

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A